The global obesity epidemic drives a cascade of lipid metabolism disorders, including hyperlipidemia, non-alcoholic fatty liver disease (NAFLD), and leptin resistance. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.